The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.

As promised, federal health officials this week dropped longstanding recommendations that healthy children and healthy ...

Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older and those 12 to ...

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

Moderna Inc. gained US approval for a new Covid vaccine for a narrower group of people, in the latest sign that regulators ...

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

The U.S. Food and Drug Administration has approved Moderna's next-generation COVID-19 vaccine for everyone aged 65 and above, ...

RFK Jr. announced this week that the federal government is removing the recommendation that kids and pregnant women get ...

The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...